Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome

OBJECTIVE: The European Increlex(®) Growth Forum Database Registry monitors the effectiveness and safety of recombinant human insulin-like growth factor-1 (rhIGF1; mecasermin, Increlex(®)) therapy in patients with severe primary IGF1 deficiency (SPIGFD). We present data from patients with and withou...

Descripción completa

Detalles Bibliográficos
Autores principales: Bang, Peter, Woelfle, Joachim, Perrot, Valerie, Sert, Caroline, Polak, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849377/
https://www.ncbi.nlm.nih.gov/pubmed/33434161
http://dx.doi.org/10.1530/EJE-20-0325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849377/
https://www.ncbi.nlm.nih.gov/pubmed/33434161
http://dx.doi.org/10.1530/EJE-20-0325

Ejemplares similares